Rehmannia glutinosa Suppresses Inflammatory Responses Elicited by Advanced Glycation End Products
- 515 Downloads
Fresh rhizome of Rehmannia glutinosa Libosch. (Saeng-jihwang in Korean: SJH) has been prescribed for the treatment of diabetes-associated complications. The purpose of the present study is to investigate the underlying mechanisms of the efficacy of SJH in diabetes-related complications. Decoction was obtained after boiling SJH in water and subsequent lyophilization. The cellular toxicity of SJH was determined by MTT assay. The antioxidant activity of SJH was measured by DPPH and DCFH-DA assays. The effects of SJH on inflammatory responses elicited by AGEs were assessed by western blotting and semi-quantitative RT-PCR analyses. The water extract of SJH had a high free radical scavenging activity in vitro and decreased the level of intracellular ROS in THP-1 cells treated with AGEs. SJH suppressed the expression of pro-inflammatory genes, including TNF-α, MCP-1, IP-10, COX-2, and iNOS; the activation of NF-κB; and the expression of RAGE, a receptor for AGEs, where the expressions of which were induced by AGEs. These results suggest the possibility that SJH can be an alternative therapeutics for diabetes-associated diseases.
KEY WORDSRehmannia glutinosa advanced glycation end products THP-1 NF-κB pro-inflammation
This work was in part supported by a grant from Ministry of Education Science and Technology KGM2250911 (M.J.).
- 10.Fosmark, D.S., P.A. Torjesen, B.K. Kilhovd, T.J. Berg, L. Sandvik, K.F. Hanssen, et al. 2006. Increased serum levels of the specific advanced glycation end product methylglyoxal-derived hydroimidazolone are associated with retinopathy in patients with type 2 diabetes mellitus. Metabolism, Clinical and Experimental 55: 232–236.CrossRefGoogle Scholar
- 21.Kiho, T., T. Watanabe, K. Nagai, and S. Ukai. 1992. Hypoglycemic activity of polysaccharide fraction from rhizome of Rehmannia glutinosa Libosch. f. hueichingensis Hsiao and the effect on carbohydrate metabolism in normal mouse liver. Yakugaku zasshi: Journal of the Pharmaceutical Society of Japan 112: 393–400.PubMedGoogle Scholar
- 24.Kim, H.M., C.S. An, K.Y. Jung, Y.K. Choo, J.K. Park, and S.Y. Nam. 1999. Rehmannia glutinosa inhibits tumour necrosis factor-alpha and interleukin-1 secretion from mouse astrocytes. Pharmacological research: the official journal of the Italian Pharmacological Society 40: 171–176.CrossRefGoogle Scholar
- 27.Brandwilliams, W., M.E. Cuvelier, and C. Berset. 1995. Use of a free-radical method to evaluate antioxidant activity. Food Sci Technol-Lebensm-Wiss Technol 28: 25–30.Google Scholar
- 35.Pouliot, M., J. Baillargeon, J.C. Lee, L.G. Cleland, and M.J. James. 1997. Inhibition of prostaglandin endoperoxide synthase-2 expression in stimulated human monocytes by inhibitors of p38 mitogen-activated protein kinase. Journal of Immunology 158: 4930–4937.Google Scholar
- 37.Lander, H.M., J.S. Ogiste, R.A. Moss, D. Stern, and A.M. Schmidt. 1995. Advanced glycation endproducts (ages) induce activation of nuclear factor-kappaB (NF-kB) by a signaling mechanism involving p21(ras) and map kinase via the receptor for ages (rage). Circulation 92: 532–532.Google Scholar
- 43.Lander, H.M., J.M. Tauras, J.S. Ogiste, O. Hori, R.A. Moss, and A.M. Schmidt. 1997. Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress. Journal of Biological Chemistry 272: 17810–17814.PubMedCrossRefGoogle Scholar
- 45.Yamagishi, S.I., K. Nakamura, T. Matsui, S. Ueda, K. Fukami, and S. Okuda. 2008. Agents that block advanced glycation end product (AGE)-RAGE (receptor for AGEs)-oxidative stress system: a novel therapeutic strategy for diabetic vascular complications. Expert Opinion on Investigational Drugs 17: 983–996.PubMedCrossRefGoogle Scholar
- 46.Jiang, Y., D.I. Beller, G. Frendl, and D.T. Graves. 1992. Monocyte chemoattractant protein-1 regulates adhesion molecule expression and cytokine production in human monocytes. Journal of Immunology 148: 2423–2428.Google Scholar
- 52.Li, S.L., J.Z. Song, C.F. Qiao, Y. Zhou, K. Qian, K.H. Lee, et al. 2010. A novel strategy to rapidly explore potential chemical markers for the discrimination between raw and processed radix rehmanniae by UHPLC-TOFMS with multivariate statistical analysis. Journal of Pharmaceutical and Biomedical Analysis 51: 812–823.PubMedCrossRefGoogle Scholar
- 55.Shieh, J.P., K.C. Cheng, H.H. Chung, Y.F. Kerh, C.H. Yeh, and J.T. Cheng. 2011. Plasma glucose lowering mechanisms of catalpol, an active principle from roots of Rehmannia glutinosa, in streptozotocin-induced diabetic rats. Journal of Agricultural and Food Chemistry 59: 3747–3753.PubMedCrossRefGoogle Scholar